Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 219 institutions that hold shares in the stock, with a total of 70.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.71 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,666,666
shares
|
$223 Million
3.24% of portfolio
|
Q4 2023
Added 15.65%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
4,520,595
shares
|
$178 Million
1.73% of portfolio
|
Q4 2024
Reduced 1.63%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,777,611
shares
|
$149 Million
0.03% of portfolio
|
Q4 2024
Reduced 1.71%
|
|
Braidwell LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
2,913,964
shares
|
$115 Million
6.4% of portfolio
|
Q4 2024
Added 7.64%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,866,755
shares
|
$113 Million
0.06% of portfolio
|
Q4 2024
Added 12.32%
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,740,000
shares
|
$108 Million
10.76% of portfolio
|
Q4 2024
Added 1.48%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,697,657
shares
|
$106 Million
0.65% of portfolio
|
Q4 2024
Added 10.35%
|
|
Capital International Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
2,547,210
shares
|
$100 Million
0.02% of portfolio
|
Q4 2024
Reduced 1.32%
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
2,294,537
shares
|
$90.4 Million
0.01% of portfolio
|
Q4 2024
Reduced 14.43%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,095,894
shares
|
$82.5 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.23%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,032,730
shares
|
$80 Million
0.09% of portfolio
|
Q2 2023
Added 1.42%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,863,473
shares
|
$73.4 Million
0.13% of portfolio
|
Q4 2024
Reduced 10.58%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,496,511
shares
|
$58.9 Million
0.07% of portfolio
|
Q4 2024
Reduced 2.11%
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
1,443,180
shares
|
$56.8 Million
0.02% of portfolio
|
Q4 2024
Added 1.29%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,437,831
shares
|
$56.6 Million
0.03% of portfolio
|
Q4 2024
Reduced 4.39%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,356,895
shares
|
$53.4 Million
0.0% of portfolio
|
Q4 2024
Added 38.91%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,251,859
shares
|
$49.3 Million
1.96% of portfolio
|
Q4 2024
Reduced 4.91%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
1,161,237
shares
|
$45.7 Million
8.14% of portfolio
|
Q4 2024
Added 1.5%
|
|
First Light Asset Management, LLC
Edina, MN |
Feb 14, 2025 Q4 2024 |
1,160,580
shares
|
$45.7 Million
4.45% of portfolio
|
Q4 2024
Reduced 1.78%
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,157,189
shares
|
$45.6 Million
0.21% of portfolio
|
Q4 2024
Added 72.82%
|
|
Samlyn Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,017,838
shares
|
$40.1 Million
0.64% of portfolio
|
Q4 2024
Reduced 0.23%
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
993,679
shares
|
$39.1 Million
0.43% of portfolio
|
Q4 2023
Added 32.2%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
947,877
shares
|
$37.3 Million
1.01% of portfolio
|
Q4 2024
Added 4.0%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
899,718
shares
|
$35.4 Million
0.04% of portfolio
|
Q4 2024
Reduced 24.74%
|
|
Times Square Capital Management, LLC
|
Feb 03, 2025 Q4 2024 |
848,850
shares
|
$33.4 Million
0.51% of portfolio
|
Q4 2024
Added 9.07%
|